Yahoo! Finance: VIAP NewsLatest Financial News for VIA PHARMACEUTICALSVIA Pharmaceuticals to Present at American Heart Association Scientific Sessions 2008 (PR Newswire)- September 15, 2008 VIA Pharmaceuticals, Inc. , a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that two abstracts on the company's Phase 2 trials of VIA-2291 in patients with acute coronary syndrome and in patients undergoing carotid endarterectomy surgery, have been accepted for presentation at the American Heart Association Scientific Sessions 2008, taking place November 8-12 in New Orleans, LA.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080915/aqm141.h... VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16 (PR Newswire)- September 9, 2008 VIA Pharmaceuticals, Inc. , a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that it will host a science briefing on Tuesday, September 16, 2008 at 12:00pm Eastern Time in New York City.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080909/aqtu066.... VIA Pharmaceuticals to Present at Merriman Curhan Ford's Investor Summit 2008 (PR Newswire)- September 9, 2008 VIA Pharmaceuticals , a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that James G. Stewart, senior vice president and chief financial officer, will present a company update at Merriman Curhan Ford's 5th annual Investor Summit on Monday, September 15, 2008 at 8 a.m.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080909/aqtu067.... |